Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics

Background: Severe mental illnesses are associated with increased risks for metabolic syndrome (MetS) and other medical disorders, often with unfavorable outcomes. MetS may be more likely with schizoaffective disorder (SzAff) than schizophrenia (Sz). MetS is associated with long-term antipsychotic d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ventriglio, Antonio, Baldessarini, Ross J., Vitrani, Giovanna, Bonfitto, Iris, Cecere, Angela Chiara, Rinaldi, Angelo, Petito, Annamaria, Bellomo, Antonello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343459/
https://www.ncbi.nlm.nih.gov/pubmed/30700975
http://dx.doi.org/10.3389/fpsyt.2018.00744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343459/
https://www.ncbi.nlm.nih.gov/pubmed/30700975
http://dx.doi.org/10.3389/fpsyt.2018.00744

Ejemplares similares